{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:22:12Z","timestamp":1785324132882,"version":"3.55.0"},"reference-count":113,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea (NRF), Korea Government","doi-asserted-by":"publisher","award":["2019R1F1A1044048"],"award-info":[{"award-number":["2019R1F1A1044048"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Defective solute carrier (SLC) transporters are responsible for neurotransmitter dysregulation, resulting in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). We provided the role and kinetic parameters of transporters such as ASCTs, Taut, LAT1, CAT1, MCTs, OCTNs, CHT, and CTL1, which are mainly responsible for the transport of essential nutrients, acidic, and basic drugs in blood\u2013brain barrier (BBB) and motor neuron disease. The affinity for LAT1 was higher in the BBB than in the ALS model cell line, whereas the capacity was higher in the NSC-34 cell lines than in the BBB. Affinity for MCTs was lower in the BBB than in the NSC-34 cell lines. CHT in BBB showed two affinity sites, whereas no expression was observed in ALS cell lines. CTL1 was the main transporter for choline in ALS cell lines. The half maximal inhibitory concentration (IC50) analysis of [3H]choline uptake indicated that choline is sensitive in TR-BBB cells, whereas amiloride is most sensitive in ALS cell lines. Knowledge of the transport systems in the BBB and motor neurons will help to deliver drugs to the brain and develop the therapeutic strategy for treating CNS and neurological diseases.<\/jats:p>","DOI":"10.3390\/pharmaceutics14102167","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T02:10:27Z","timestamp":1665540627000},"page":"2167","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Blood\u2013Brain Barrier Solute Carrier Transporters and Motor Neuron Disease"],"prefix":"10.3390","volume":"14","author":[{"given":"Sana","family":"Latif","sequence":"first","affiliation":[{"name":"Research Institute of Pharmaceutical Sciences, College of Pharmacy, Sookmyung Women\u2019s University, 100 Cheongpa-ro 47-gil, Yongsan-gu, Seoul 04310, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-4657","authenticated-orcid":false,"given":"Young-Sook","family":"Kang","sequence":"additional","affiliation":[{"name":"Research Institute of Pharmaceutical Sciences, College of Pharmacy, Sookmyung Women\u2019s University, 100 Cheongpa-ro 47-gil, Yongsan-gu, Seoul 04310, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00424-003-1192-y","article-title":"The ABCs of solute carriers: Physiological, pathological and therapeutic implications of human membrane transport proteins","volume":"447","author":"Hediger","year":"2004","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: Emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1152\/physiol.00045.2007","article-title":"Apical transporters for neutral amino acids: Physiology and pathophysiology","volume":"23","year":"2008","journal-title":"Physiology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","article-title":"The SLC3 and SLC7 families of amino acid transporters","volume":"34","author":"Fotiadis","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3389\/fphys.2020.00973","article-title":"Transport of amino acids across the blood-brain barrier","volume":"11","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ajps.2019.09.002","article-title":"The solute carrier transporters and the brain: Physiological and pharmacological implications","volume":"15","author":"Hu","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/03602532.2018.1512614","article-title":"Subcellular drug distribution: Mechanisms and roles in drug efficacy, toxicity, resistance, and targeted delivery","volume":"50","author":"Li","year":"2018","journal-title":"Drug Metab. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11064-016-2030-x","article-title":"Solute Carriers in the Blood\u2013Brain Barrier: Safety in Abundance","volume":"42","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","article-title":"Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery","volume":"54","author":"Patching","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2741\/4636","article-title":"Choline, the brain and neurodegeneration: Insights from epigenetics","volume":"23","author":"Bekdash","year":"2018","journal-title":"Front. Biosci.-Landmark"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.9758\/cpn.2020.18.2.174","article-title":"The role of the SLC transporters protein in the neurodegenerative disorders","volume":"18","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","article-title":"Amyotrophic lateral sclerosis: Mechanisms and therapeutics in the epigenomic era","volume":"11","author":"Sakowski","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bbrc.2009.05.015","article-title":"Motor neuronal protection by l-arginine prolongs survival of mutant SOD1 (G93A) ALS mice","volume":"384","author":"Lee","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuint.2011.10.017","article-title":"Riluzole elevates GLT-1 activity and levels in striatal astrocytes","volume":"60","author":"Carbone","year":"2012","journal-title":"Neurochem. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijdevneu.2013.06.002","article-title":"Riluzole increases glutamate uptake by cultured C6 astroglial cells","volume":"31","author":"Bobermin","year":"2013","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejphar.2003.08.073","article-title":"The glutamate and neutral amino acid transporter family: Physiological and pharmacological implications","volume":"479","author":"Kanai","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","article-title":"An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria","volume":"14","author":"Wong","year":"1995","journal-title":"Neuron"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1093\/brain\/awr193","article-title":"Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis","volume":"134","author":"Ferraiuolo","year":"2011","journal-title":"Brain"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12035-012-8371-9","article-title":"Expression of taurine transporter (TauT) is modulated by heat shock factor 1 (HSF1) in motor neurons of ALS","volume":"47","author":"Jung","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/aja.1001940306","article-title":"Neuroblastoma \u00d7 spinal cord (NSC) hybrid cell lines resemble developing motor neurons","volume":"194","author":"Cashman","year":"1992","journal-title":"Dev. Dyn."},{"key":"ref_23","unstructured":"Gomes, C.H. (2015). Amyotrophic Lateral Sclerosis: Mammalian Cell Models, Copper-Zinc Superoxide Dismutase and Biological Characteristics, Universidade NOVA de Lisboa (Portugal)\u2009ProQuest Dissertations Publishing."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4062\/biomolther.2021.037","article-title":"Change in cationic amino acid transport system and effect of lysine pretreatment on inflammatory state in amyotrophic lateral sclerosis cell model","volume":"29","author":"Latif","year":"2021","journal-title":"Biomol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Gyawali, A., Hyeon, S.J., Ryu, H., and Kang, Y.S. (2021). The alteration of l-carnitine transport and pretreatment effect under glutamate cytotoxicity on motor neuron-like NSC-34 lines. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040551"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s11095-007-9374-5","article-title":"Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development","volume":"24","author":"Ohtsuki","year":"2007","journal-title":"Pharm. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/10611860008997912","article-title":"MRNA expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting","volume":"8","author":"Hosoya","year":"2000","journal-title":"J. Drug Target."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"863836","DOI":"10.3389\/fncel.2022.863836","article-title":"Study of BBB Dysregulation in Neuropathogenicity Using Integrative Human Model of Blood\u2013Brain Barrier","volume":"16","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/17425255.1.2.325","article-title":"The rise of PAMPA","volume":"1","author":"Avdeef","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mvr.2018.05.010","article-title":"l-Citrulline restores nitric oxide level and cellular uptake at the brain capillary endothelial cell line (TR-BBB cells) with glutamate cytotoxicity","volume":"120","author":"Lee","year":"2018","journal-title":"Microvasc. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12987-021-00291-y","article-title":"Next-generation in vitro blood\u2013brain barrier models: Benchmarking and improving model accuracy","volume":"18","author":"Linville","year":"2021","journal-title":"Fluids Barriers CNS"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yahyaoui, R., and P\u00e9rez-Fr\u00edas, J. (2020). Amino acid transport defects in human inherited metabolic disorders. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010119"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1073\/pnas.1722677115","article-title":"ASCT1 (Slc1a4) transporter is a physiologic regulator of brain D-serine and neurodevelopment","volume":"115","author":"Kaplan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1042\/BCJ20160822","article-title":"Amino acid homeostasis and signalling in mammalian cells and organisms","volume":"474","year":"2017","journal-title":"Biochem. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fcell.2018.00096","article-title":"The Human SLC1A5 (ASCT2) amino acid transporter: From function to structure and role in cell biology","volume":"6","author":"Scalise","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1073\/pnas.97.9.4926","article-title":"D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor","volume":"97","author":"Mothet","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","unstructured":"Levin, E.D., and Buccafusco, J.J. (2019). Involvement of the NMDA System in Learning and Memory. Animal Models of Cognitive Impairme, CRC Press\/Taylor & Francis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1038\/sj.emboj.7601840","article-title":"D-Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis","volume":"26","author":"Sasabe","year":"2007","journal-title":"EMBO J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1073\/pnas.1114639109","article-title":"D-Amino acid oxidase controls motoneuron degeneration through D-serine","volume":"109","author":"Sasabe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00726-012-1385-9","article-title":"The role of D-amino acids in amyotrophic lateral sclerosis pathogenesis: A review","volume":"43","author":"Paul","year":"2012","journal-title":"Amino Acids"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2016.12.178","article-title":"The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS)","volume":"483","author":"Lee","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1471-4159.2011.07601.x","article-title":"Paradoxical roles of serine racemase and d -serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis","volume":"120","author":"Thompson","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12929-017-0336-x","article-title":"Characteristics of L-citrulline transport through blood-brain barrier in the brain capillary endothelial cell line (TR-BBB cells)","volume":"24","author":"Lee","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12035-020-02143-6","article-title":"L-Citrulline level and transporter activity are altered in experimental models of amyotrophic lateral sclerosis","volume":"58","author":"Gyawali","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Latif, S., and Kang, Y.S. (2021). Differences of transport activity of arginine and regulation on neuronal nitric oxide synthase and oxidative stress in amyotrophic lateral sclerosis model cell lines. Cells, 10.","DOI":"10.3390\/cells10123554"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s11095-016-1912-6","article-title":"In Vivo and In Vitro Evidence for Brain Uptake of 4-Phenylbutyrate by the Monocarboxylate Transporter 1 (MCT1)","volume":"33","author":"Lee","year":"2016","journal-title":"Pharm. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.xphs.2020.10.030","article-title":"Transport alteration of 4-phenyl butyric acid mediated by a sodium- and proton-coupled monocarboxylic acid transporter system in ALS model cell lines (NSC-34) under inflammatory states","volume":"110","author":"Gyawali","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s11064-012-0723-3","article-title":"The acetylcholinesterase inhibitors competitively inhibited an acetyl L-carnitine transport through the blood-brain barrier","volume":"37","author":"Lee","year":"2012","journal-title":"Neurochem. Res."},{"key":"ref_50","first-page":"353","article-title":"In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier","volume":"6","author":"Kang","year":"1990","journal-title":"J. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.bbamem.2008.04.012","article-title":"ichi Function of taurine transporter (Slc6a6\/TauT) as a GABA transporting protein and its relevance to GABA transport in rat retinal capillary endothelial cells","volume":"1778","author":"Tomi","year":"2008","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3892\/mmr.2020.11321","article-title":"Significance of taurine transporter (TauT) in homeostasis and its layers of regulation (review)","volume":"22","author":"Baliou","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1203\/01.PDR.0000102702.39608.82","article-title":"Relationship between cerebral interstitial levels of amino acids and phosphorylation potential during secondary energy failure in hypoxic-ischemic newborn piglets","volume":"55","author":"Kusaka","year":"2004","journal-title":"Pediatr. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s007260070003","article-title":"Taurine and neural cell damage Review Article","volume":"19","author":"Saransaari","year":"2000","journal-title":"Amino Acids"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/0-306-46838-7_36","article-title":"Taurine transport mechanism through the blood-brain barrier in spontaneously hypertensive rats","volume":"483","author":"Kang","year":"2000","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1046\/j.1471-4159.2002.01223.x","article-title":"Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-\u03b1, taurine and hypertonicity","volume":"83","author":"Kang","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/0006-2952(95)02046-2","article-title":"Na+- and Cl--Dependent transport of taurine at the blood-brain barrier","volume":"50","author":"Tamai","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbadis.2006.03.006","article-title":"Transgenic mouse models of amyotrophic lateral sclerosis","volume":"1762","author":"Julien","year":"2006","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/978-94-024-1079-2_70","article-title":"Taurine protects glutamate neurotoxicity in motor neuron cells","volume":"975","author":"Lee","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00424-003-1086-z","article-title":"CATs and HATs: The SLC7 family of amino acid transporters","volume":"447","author":"Verrey","year":"2004","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/physrev.1990.70.1.43","article-title":"Role of amino acid transport and countertransport in nutrition and metabolism","volume":"70","author":"Christensen","year":"1990","journal-title":"Physiol. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2018.00243","article-title":"The human SLC7A5 (LAT1): The intriguing histidine\/large neutral amino acid transporter and its relevance to human health","volume":"6","author":"Scalise","year":"2018","journal-title":"Front. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"564809","DOI":"10.3389\/fchem.2020.564809","article-title":"Review of the Correlation of LAT1 With Diseases: Mechanism and Treatment","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.clnu.2008.08.003","article-title":"Mechanisms and kinetics of citrulline uptake in a model of human intestinal epithelial cells","volume":"27","author":"Bahri","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainres.2013.05.011","article-title":"Oral l-Citrulline administration improves memory deficits following transient brain ischemia through cerebrovascular protection","volume":"1520","author":"Yabuki","year":"2013","journal-title":"Brain Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000017468","article-title":"Transport of L-citrulline in neural cell cultures","volume":"22","author":"Schmidlin","year":"2000","journal-title":"Dev. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1476-5381.1994.tb13099.x","article-title":"Discrimination between citrulline and arginine transport in activated murine macrophages: Inefficient synthesis of NO from recycling of citrulline to arginine","volume":"112","author":"Baydoun","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40635-019-0274-x","article-title":"Bench to bedside review: Therapeutic modulation of nitric oxide in sepsis\u2014An update","volume":"7","author":"Lambden","year":"2019","journal-title":"Intensive Care Med. Exp."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gyawali, A., and Kang, Y.S. (2021). Pretreatment effect of inflammatory stimuli and characteristics of tryptophan transport on brain capillary endothelial (Tr-BBB) and motor neuron like (NSC-34) cell lines. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010009"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1097\/00001756-200011090-00021","article-title":"Expression of a system L neutral amino acid transporter at the blood-brain barrier","volume":"11","author":"Matsuo","year":"2000","journal-title":"Neuroreport"},{"key":"ref_71","first-page":"147","article-title":"Excitotoxicity and amyotrophic lateral sclerosis","volume":"2","author":"Dewil","year":"2006","journal-title":"Neurodegener. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/med.21528","article-title":"Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs","volume":"39","author":"Jaiswal","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12929-022-00785-3","article-title":"Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis","volume":"29","author":"Gyawali","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41467-018-03066-6","article-title":"Structural basis for amino acid transport by the CAT family of SLC7 transporters","volume":"9","author":"Jungnickel","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_75","first-page":"95","article-title":"Exploring targets and therapies for amyotrophic lateral sclerosis: Current insights into dietary interventions","volume":"7","author":"Ngo","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1152\/ajpendo.00007.2006","article-title":"Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+","volume":"291","author":"Simpson","year":"2006","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"526","DOI":"10.15252\/emmm.201404433","article-title":"A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Palamiuc","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1471-4159.2009.06367.x","article-title":"Cationic amino acid transporter 1-mediated l-arginine transport at the inner blood-retinal barrier","volume":"111","author":"Tomi","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00424-003-1067-2","article-title":"The SLC16 gene family\u2014From monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond","volume":"447","author":"Halestrap","year":"2004","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.573","article-title":"The monocarboxylate transporter family-Structure and functional characterization","volume":"64","author":"Halestrap","year":"2012","journal-title":"IUBMB Life"},{"key":"ref_81","first-page":"113","article-title":"Partial Pyridoxine Responsiveness in PNPO Deficiency","volume":"4","author":"Pearl","year":"2012","journal-title":"JIMD Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family-Structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ejpb.2008.05.022","article-title":"Transport of valproate at intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells: Mechanism and substrate specificity","volume":"70","author":"Fischer","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1208\/s12248-008-9022-y","article-title":"Sodium-coupled monocarboxylate transporters in normal tissues and in cancer","volume":"10","author":"Ganapathy","year":"2008","journal-title":"AAPS J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.mp.4000805","article-title":"Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: Relevance for its mode of action in Alzheimer\u2019s disease and geriatric depression","volume":"5","author":"Pettegrew","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1471-4159.2006.03757.x","article-title":"Functional expression of the organic cation\/carnitine transporter 2 in rat astrocytes","volume":"97","author":"Inazu","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1007\/s11064-013-1144-7","article-title":"L-carnitine exposure and mitochondrial function in human neuronal cells","volume":"38","author":"Geier","year":"2013","journal-title":"Neurochem. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0006-2952(97)00670-9","article-title":"Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transporter deficiency","volume":"55","author":"Hashimoto","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11064-010-0131-5","article-title":"High affinity carnitine transporters from OCTN family in neural cells","volume":"35","author":"Januszewicz","year":"2010","journal-title":"Neurochem. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1095\/biolreprod67.1.314","article-title":"Organic cation\/carnitine transporter, OCTN2, is differentially expressed in the adult rat epididymis","volume":"67","author":"Labus","year":"2002","journal-title":"Biol. Reprod."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1006\/bbrc.1998.9679","article-title":"Carnitine uptake defect: Frameshift mutations in the human plasmalemmal carnitine transporter gene","volume":"252","author":"Lamhonwah","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Latif, S., Choi, S., Gyawali, A., Hyeon, S.J., Kang, Y., and Ryu, H. (2022). Antioxidant and neuroprotective effects of paeonol against oxidative stress and altered carrier-mediated transport system on NSC-34 cell lines. Antioxidants, 11.","DOI":"10.3390\/antiox11071392"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.placenta.2009.01.011","article-title":"Choline transport via choline transporter-like protein 1 in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBT","volume":"30","author":"Lee","year":"2009","journal-title":"Placenta"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"9851","DOI":"10.1523\/JNEUROSCI.1862-06.2006","article-title":"Na+, Cl\u2212, and pH dependence of the human choline transporter (hCHT) in Xenopus oocytes: The proton inactivation hypothesis of hCHT in synaptic vesicles","volume":"26","author":"Iwamoto","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuint.2017.05.022","article-title":"Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity","volume":"108","author":"Parikh","year":"2017","journal-title":"Neurochem. Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"104810","DOI":"10.1016\/j.neuint.2020.104810","article-title":"Modulation of sodium-coupled choline transporter CHT function in health and disease","volume":"140","author":"Ojiakor","year":"2020","journal-title":"Neurochem. Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/1535370219830997","article-title":"Choline transport for phospholipid synthesis: An emerging role of choline transporter-like protein 1","volume":"244","author":"Hedtke","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/153537020623100503","article-title":"Choline transport for phospholipid synthesis","volume":"231","author":"Michel","year":"2006","journal-title":"Exp. Biol. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1073\/pnas.030339697","article-title":"An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transporter-like proteins","volume":"97","author":"Traiffort","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gene.2004.07.042","article-title":"Identification and expression of a mouse muscle-specific CTL1 gene","volume":"341","author":"Yuan","year":"2004","journal-title":"Gene"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.4049\/jimmunol.167.10.5795","article-title":"Characterization of CDw92 as a Member of the choline transporter-like protein family regulated specifically on dendritic cells","volume":"167","author":"Wille","year":"2001","journal-title":"J. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1096\/fj.08-121491","article-title":"The solute carrier 44A1 is a mitochondrial protein and mediates choline transport","volume":"23","author":"Michel","year":"2009","journal-title":"FASEB J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"100604","DOI":"10.1016\/j.jbc.2021.100604","article-title":"Choline transporter-like proteins 1 and 2 are newly identified plasma membrane and mitochondrial ethanolamine transporters","volume":"296","author":"Taylor","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"41611","DOI":"10.1074\/jbc.M108472200","article-title":"Ventricular choline transport: A role for organic cation transporter 2 expressed in choroid plexus","volume":"276","author":"Sweet","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fneng.2013.00007","article-title":"The blood-brain barrier: An engineering perspective","volume":"6","author":"Wong","year":"2013","journal-title":"Front. Neuroeng."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF02977674","article-title":"Donepezil, Tacrine and \u03b1-Phenyl-n-tert-Butyl Nitrone (PBN) Inhibit Choline Transport by Conditionally Immortalized Rat","volume":"28","author":"Kang","year":"2005","journal-title":"Arch. Pharm. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2005.03299.x","article-title":"Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes","volume":"94","author":"Inazu","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1745-7270.2007.00323.x","article-title":"Choline transporters in human lung adenocarcinoma: Expression and functional implications","volume":"39","author":"Wang","year":"2007","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_109","first-page":"351","article-title":"Identification and characterization of the high-affinity choline transporter","volume":"299","author":"Okuda","year":"2000","journal-title":"Nat. Am. Inc."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jb\/mvu047","article-title":"Molecular properties of the high-affinity choline transporter CHT1","volume":"156","author":"Haga","year":"2014","journal-title":"J. Biochem."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Inazu, M. (2019). Functional expression of choline transporters in the blood-brain barrier. Nutrients, 11.","DOI":"10.3390\/nu11102265"},{"key":"ref_112","first-page":"531","article-title":"Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: The influence of prior agonist exposure on receptor responsiveness","volume":"29","author":"Brown","year":"1986","journal-title":"Mol. Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/HYPERTENSIONAHA.109.137992","article-title":"Effect of epithelial sodium channel blockade on the myogenic response of rat juxtamedullary afferent arterioles","volume":"54","author":"Guan","year":"2009","journal-title":"Hypertension"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/10\/2167\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:50:07Z","timestamp":1760143807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/10\/2167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":113,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["pharmaceutics14102167"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14102167","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]}}}